Shopping Cart

No products in the cart.

CGA PS-42-2018

$33.15

CGA Position Statement on Appropriate and Effective Regulations for Medical Gases within 21 CFR Parts 201, 205, and 210/211

Published By Publication Date Number of Pages
CGA 2018-01-01 44
Guaranteed Safe Checkout
Category:

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

This position statement reflects the Compressed Gas Association?s (CGA) consensus position for how the FDA?s regulations for finished pharmaceuticals found in Title 21 of the U.S. Code of Federal Regulations (21 CFR) Parts 201 (labeling), 205 (wholesale distribution), and 210 and 211 (GMPs), should be revised for designated medical gases or combinations thereof. This position is consistent with established and long standing industry practice yielding safe and efficacious designated medical gases and consistent with the Congressional intent in the FDASIA identifying the need for revisions to 21 CFR.

CGA PS-42-2018
$33.15